CN104138456A - Medicine for treating arrhythmia heart blood stasis type coronary heart disease - Google Patents

Medicine for treating arrhythmia heart blood stasis type coronary heart disease Download PDF

Info

Publication number
CN104138456A
CN104138456A CN201310171565.1A CN201310171565A CN104138456A CN 104138456 A CN104138456 A CN 104138456A CN 201310171565 A CN201310171565 A CN 201310171565A CN 104138456 A CN104138456 A CN 104138456A
Authority
CN
China
Prior art keywords
medicine
blood stasis
heart disease
coronary heart
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201310171565.1A
Other languages
Chinese (zh)
Inventor
雷雨山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARBIN JITONG BIOLOGICAL TECHNOLOGY DEVELOPMENT Co Ltd
Original Assignee
HARBIN JITONG BIOLOGICAL TECHNOLOGY DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HARBIN JITONG BIOLOGICAL TECHNOLOGY DEVELOPMENT Co Ltd filed Critical HARBIN JITONG BIOLOGICAL TECHNOLOGY DEVELOPMENT Co Ltd
Priority to CN201310171565.1A priority Critical patent/CN104138456A/en
Publication of CN104138456A publication Critical patent/CN104138456A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of medicines, and concretely relates to a medicine for treating the arrhythmia heart blood stasis type coronary heart disease. The medicine comprises 15g of Ligusticum wallichii, 25g of Salvia miltiorrhiza, 15g of Radix Paeoniae Rubra, 8g of safflower, 10g of Panax Notoginseng, 10g of Corydalis tuber, 10g of green tangerine peel, 15g of unprepared rehmannia root, 15g of Chinese angelica, 10g of Platycladi Seed and 10g of Chinese magnoliavine. The medicine is prepared through the following steps: mixing the above medicines, flushing, immersing for 3h, boiling for 30min three times, filtering, carrying out vacuum dehydration drying, and processing through a routine traditional Chinese medicine preparation method to prepare a tablet. One dose of the medicine is administrated three times every day, and the one dose equals to 30g of the water decoction of raw medicines. The medicine is used for treating the arrhythmia heart blood stasis type coronary heart disease, and has the efficacies of blood circulation invigorating, blood stasis dissolving, qi rectifying, vein relaxing, heart nourishing and mind tranquilizing.

Description

A kind of medicine for the treatment of arrhythmia cardiovascular stasis coronary heart disease
Technical field
The present invention relates to field of pharmaceutical technology, specifically a kind of medicine for the treatment of arrhythmia cardiovascular stasis coronary heart disease.
Background technology
The main manifestations of coronary heart disease has angina pectoris, arrhythmia, myocardial infarction, heart failure.The present invention be directed to coronary heart disease and arrhythmia, comprise premature beat, atrioventricular block, atrial fibrillation, paroxysmal tachycardia etc.Arrhythmia belongs to cardiopalmus in the traditional Chinese medical science, and palpitation with a distress feeling category has timidness due to deficiency of the heart type in the dialectical thing of tcm clinical practice treats, type of insufficiency of heart-blood, and type of hyperactivity of fire caused by deficiency of YIN, flaccidity of the heart-yang type, water is insulted heart type, type of obstruction of heart-blood.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of arrhythmia cardiovascular stasis coronary heart disease.
The medicine that the present invention treats arrhythmia cardiovascular stasis coronary heart disease is comprised of the formula of following weight portion:
Rhizoma Chuanxiong 15g, Radix Salviae Miltiorrhizae 25g, Radix Paeoniae Rubra 15g, Flos Carthami 8g, Radix Notoginseng 10g, Rhizoma Corydalis 10g, Pericarpium Citri Reticulatae Viride 10g, Radix Rehmanniae 15g, Radix Angelicae Sinensis 15g, Semen Platycladi, Fructus Schisandrae Chinensis 10g.
Preparation method:
Above-mentioned each taste medicine is mixed, after rinsing, soak 3 hours, boil three times, each 30 minutes, to filter, vacuum dehydration is dry, adopts the conventional method of Chinese medicine preparation to be prepared into tablet.
Instructions of taking: be equivalent to the 30g water decoction of crude drug each serving consumption, every day three times.
Medicine blood circulation promoting and blood stasis dispelling of the present invention, regulating qi and dredging collateral, the effect of tranquilizing by nourishing the heart.
Model case:
Chen Shulin, man 67 years old, workman, heart cardiopalmus, breathes hard, dizzy weak, left little finger of toe fiber crops, one year more than, often take quinine fourth, propranolol treatment, effect is not remarkable, and outbreak repeatedly.First visit: intermittent pulse, purplish tongue has ecchymosis.Electrocardiogram prompting myocardial ischemia, arrhythmia, fibrillation, is diagnosed as coronary heart disease, arrhythmia type of obstruction of heart-blood.Take medicine of the present invention, after 14 days, take a favorable turn, take again 14 days, symptom all disappears.Electrocardiogram check shows sinus rate, 71 times per minute, continues to take 7 days to consolidate curative effect.
Diagnostic criteria: main manifestations is palpitation and restlessness, discomfort uncomfortable in chest, precordialgia, outbreak often, purplish tongue or have ecchymosis, or lip, fingernail are livid purple, irregularly intermittent and regularly intermittent pulse (unsighted Chu is word herein).
The specific embodiment
The specific embodiment one:
Present embodiment is comprised of the formula of following weight portion: Rhizoma Chuanxiong 15g, Radix Salviae Miltiorrhizae 25g, Radix Paeoniae Rubra 15g, Flos Carthami 8g, Radix Notoginseng 10g, Rhizoma Corydalis 10g, Pericarpium Citri Reticulatae Viride 10g, Radix Rehmanniae 15g, Radix Angelicae Sinensis 15g, Semen Platycladi 10g, Fructus Schisandrae Chinensis 10g.
Preparation method:
Above-mentioned each taste medicine is mixed, after rinsing, soak 3 hours, boil three times, each 30 minutes, to filter, vacuum dehydration is dry, adopts the conventional method of Chinese medicine preparation to be prepared into tablet.
Instructions of taking: be equivalent to the 30g water decoction of crude drug each serving consumption, every day three times.

Claims (1)

1. a treatment arrhythmia cardiovascular stasis coronary heart disease medicine, is characterized in that it is comprised of the formula of following weight portion: Rhizoma Chuanxiong 15g, Radix Salviae Miltiorrhizae 25g, Radix Paeoniae Rubra 15g, Flos Carthami 8g, Radix Notoginseng 10g, Rhizoma Corydalis 10g, Pericarpium Citri Reticulatae Viride 10g, Radix Rehmanniae 15g, Radix Angelicae Sinensis 15g, Semen Platycladi 10g, Fructus Schisandrae Chinensis 10g.
CN201310171565.1A 2013-05-11 2013-05-11 Medicine for treating arrhythmia heart blood stasis type coronary heart disease Withdrawn CN104138456A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310171565.1A CN104138456A (en) 2013-05-11 2013-05-11 Medicine for treating arrhythmia heart blood stasis type coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310171565.1A CN104138456A (en) 2013-05-11 2013-05-11 Medicine for treating arrhythmia heart blood stasis type coronary heart disease

Publications (1)

Publication Number Publication Date
CN104138456A true CN104138456A (en) 2014-11-12

Family

ID=51847908

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310171565.1A Withdrawn CN104138456A (en) 2013-05-11 2013-05-11 Medicine for treating arrhythmia heart blood stasis type coronary heart disease

Country Status (1)

Country Link
CN (1) CN104138456A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109758554A (en) * 2018-12-07 2019-05-17 上海中医药大学附属龙华医院 A kind of blood activating and fat reducing coronary dilatation expands blood vessel heart particle living and preparation method thereof
CN110638918A (en) * 2019-10-22 2020-01-03 广州中医药大学第一附属医院 Traditional Chinese medicine composition for treating arrhythmia caused by blood stasis in heart vessels and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109758554A (en) * 2018-12-07 2019-05-17 上海中医药大学附属龙华医院 A kind of blood activating and fat reducing coronary dilatation expands blood vessel heart particle living and preparation method thereof
CN110638918A (en) * 2019-10-22 2020-01-03 广州中医药大学第一附属医院 Traditional Chinese medicine composition for treating arrhythmia caused by blood stasis in heart vessels and application thereof

Similar Documents

Publication Publication Date Title
CN102335380A (en) Drug for treating cardiovascular and cerebrovascular diseases, and preparation method thereof
CN103301426A (en) Capsule for invigorating circulation and benefiting heart
CN103341049A (en) Dendrobium huoshanense-containing traditional Chinese medicine composition with anti-fatigue effect, and preparation method thereof
CN104138429A (en) Medicine for treating arrhythmia heart blood insufficiency type coronary heart disease
CN103330821B (en) A kind of Chinese medicine for the treatment of obstruction of qi in the chest and cardialgia
CN103417851A (en) Traditional Chinese medicine capable of clearing and activating the channels and collaterals and promoting blood circulation to remove blood stasis
CN104138515A (en) Medicine for treating arrhythmia heart yang deficiency type coronary heart disease
CN104138456A (en) Medicine for treating arrhythmia heart blood stasis type coronary heart disease
CN104138513A (en) Medicine for treating angina pectoris qi-blood deficiency type coronary heart disease
CN103349735B (en) Traditional Chinese medicine for treating hypertension
CN102462751B (en) Chinese medicine for treating arrhythmia and preparation method thereof
CN104138566A (en) Medicine for treating angina pectoris heart blood stasis type coronary heart disease
CN104138565A (en) Medicine for treating angina pectoris turbid phlegm internal stagnation type coronary heart disease
CN103083493A (en) Treatment method of rhinitis by using Chinese medicaments
CN105168856A (en) Traditional Chinese medicine preparation for treating ischemia-reperfusion type slow arrhythmia and preparation method thereof
CN101632758A (en) Chinese medicinal composition for invigorating qi and promoting blood circulation, and removing obstruction in channels to relieve pain
CN104645207A (en) Traditional Chinese medicine composition for treating angina
CN104138534A (en) Medicine for treating arrhythmia qi and heart blood insufficiency timidity type coronary heart disease
CN103690776B (en) A kind of Chinese medicine for the treatment of diabetes
CN104138512A (en) Medicine for treating angina pectoris yang energy verging-on-desertion type coronary heart disease
CN104138577A (en) Medicine for treating angina pectoris cold heart-vein type coronary heart disease
CN102755581B (en) Pharmaceutical composition for treating unstable angina pectoris
CN104138514A (en) Medicine for treating arrhythmia yin deficiency and fire excess type coronary heart disease
CN104138579A (en) Medicine for treating arrhythmia fluid retention invading heart type coronary heart disease
CN103330908A (en) Traditional Chinese medicine for treating coronary heart disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20141112